Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,259 | -3,635 | -13,213 | -9,632 | -7,271 |
| Depreciation Amortization | N/A | N/A | 21 | 3 | 3 |
| Accounts payable and accrued liabilities | -5,828 | -6,440 | 4,963 | 5,439 | 4,815 |
| Other Working Capital | -5,574 | -6,734 | 2,945 | 2,963 | 2,902 |
| Other Operating Activity | 5,865 | 6,517 | -5,560 | -5,859 | -5,158 |
| Operating Cash Flow | $-11,796 | $-10,292 | $-10,844 | $-7,085 | $-4,709 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -1 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-1 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 190 | 190 | 17,749 | 18,259 | N/A |
| Financing Cash Flow | $190 | $190 | $17,749 | $18,259 | $N/A |
| Exchange Rate Effect | N/A | N/A | -181 | -181 | 56 |
| Beginning Cash Position | 12,598 | 12,598 | 5,876 | 5,876 | 5,876 |
| End Cash Position | 993 | 2,497 | 12,598 | 16,868 | 1,223 |
| Net Cash Flow | $-11,606 | $-10,101 | $6,722 | $10,993 | $-4,653 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,796 | -10,292 | -10,844 | -7,085 | -4,709 |
| Free Cash Flow | -11,796 | -10,292 | -10,844 | -7,085 | -4,709 |